Browsing Brage INN by Author "Hammersbøen, Kristin Reine"

Now showing items 1-2 of 2

    • Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study 

      Ørbo, Hilde Sofie Sager; Hammersbøen, Kristin Reine; Sexton, Joseph; Jyssum, Ingrid; Tveter, Anne Therese; Christensen, Ingrid Egeland; Mjaaland, Siri; Kvien, Tore Kristian Aaserud; Grødeland, Gunnveig; Kro, Grete Anette Birkeland; Jahnsen, Jørgen; Haavardsholm, Espen A.; Munthe, Ludvig Andre; Provan, Sella Aarrestad; Vaage, John T.; Goll, Guro Løvik; Jørgensen, Kristin Kaasen; Syversen, Silje Watterdal (Peer reviewed; Journal article, 2024)
      Objectives To assess incidence, severity and predictors of COVID-19, including protective post-vaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike protein (anti-RBD), informing further vaccine ...

    • T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study 

      Wolf, Asia-Sophia Fumika Michaela; Hammersbøen, Kristin Reine; Ørbo, Hilde Sofie Sager; Bhandari, Sabin; Solum, Guri; Kjønstad, Ingrid Fadum; Jyssum, Ingrid; Nygaard, Unni Cecilie; Kristoffersen, Anja Bråthen; Christensen, Ingrid Egeland; Josefsson, Sarah Elisabet; Lund, Katrine Persgård; Chopra, Adity; Osen, Julie Røkke; Chaban, Viktoriia; Tveter, Anne Therese; Sexton, Joseph; Kvien, Tore Kristian Aaserud; Jahnsen, Jørgen; Haavardsholm, Espen A.; Grødeland, Gunnveig; Vaage, John T.; Provan, Sella Aarrestad; Kared, Hassen; Lund-Johansen, Fridtjof; Munthe, Ludvig Andre; Syversen, Silje Watterdal; Goll, Guro Løvik; Jørgensen, Kristin Kaasen; Mjaaland, Siri (Peer reviewed; Journal article, 2024)
      Background Understanding cellular responses to SARS-CoV-2 immunisations is important for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) and other vulnerable patients on immunosuppressive ...